Claudia R L Cardoso1, Juliana V Melo2, Thainá R M Santos2, Nathalie C Leite1, Gil F Salles3. 1. Department of Internal Medicine, University Hospital Clementino Fraga Filho, School of Medicine, Universidade Federal do Rio de Janeiro, Rua Croton, 72, Jacarepagua, Rio de Janeiro, RJ, CEP: 22750-240, Brazil. 2. Department of Occupational Therapy, University Hospital Clementino Fraga Filho, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. 3. Department of Internal Medicine, University Hospital Clementino Fraga Filho, School of Medicine, Universidade Federal do Rio de Janeiro, Rua Croton, 72, Jacarepagua, Rio de Janeiro, RJ, CEP: 22750-240, Brazil. gilsalles@hucff.ufrj.br.
Abstract
BACKGROUND: The prognostic importance of non-traditional risk factors for peripheral artery disease (PAD) development/progression is scarcely studied in diabetes. We investigated if carotid intima-media thickness (CIMT) and carotid-femoral pulse wave velocity (cf-PWV) added prognostic information beyond traditional cardiovascular risk markers for PAD outcomes. METHODS: Ankle-brachial index (ABI) was measured at baseline and after a median of 91 months of follow-up in 681 individuals with type 2 diabetes. Multivariate Cox regressions examined the associations between the candidate variables and the outcome. PAD development/progression was defined by a reduction in ABI ≥ 0.15 (to a level < 0.9) or limb revascularization procedures, lower-extremity amputations or death due to PAD. The improvement in risk discrimination was assessed by increases in C-statistics of the models. RESULTS: Seventy-seven patients developed/progressed PAD: 50 reduced ABI to < 0.9, seven had lower-limb revascularizations, and 20 had amputations or death. Age, male sex, diabetes duration, presence of microvascular complications (peripheral neuropathy and diabetic kidney disease), baseline HbA1c, 24-h systolic BP (SBP) and mean cumulative office SBP and LDL-cholesterol were associated with PAD development/progression in several models. CIMT and cf-PWV were additionally associated with PAD outcomes, and their inclusion further improved risk discrimination (with C-statistic increases between 0.025 and 0.030). The inclusion of ambulatory 24-h SBP, instead of office SBP, also improved PAD risk discrimination. CONCLUSIONS: Increased CIMT and aortic stiffness are associated with greater risks of developing/progressing PAD, beyond traditional risk factors, in type 2 diabetes.
BACKGROUND: The prognostic importance of non-traditional risk factors for peripheral artery disease (PAD) development/progression is scarcely studied in diabetes. We investigated if carotid intima-media thickness (CIMT) and carotid-femoral pulse wave velocity (cf-PWV) added prognostic information beyond traditional cardiovascular risk markers for PAD outcomes. METHODS: Ankle-brachial index (ABI) was measured at baseline and after a median of 91 months of follow-up in 681 individuals with type 2 diabetes. Multivariate Cox regressions examined the associations between the candidate variables and the outcome. PAD development/progression was defined by a reduction in ABI ≥ 0.15 (to a level < 0.9) or limb revascularization procedures, lower-extremity amputations or death due to PAD. The improvement in risk discrimination was assessed by increases in C-statistics of the models. RESULTS: Seventy-seven patients developed/progressed PAD: 50 reduced ABI to < 0.9, seven had lower-limb revascularizations, and 20 had amputations or death. Age, male sex, diabetes duration, presence of microvascular complications (peripheral neuropathy and diabetic kidney disease), baseline HbA1c, 24-h systolic BP (SBP) and mean cumulative office SBP and LDL-cholesterol were associated with PAD development/progression in several models. CIMT and cf-PWV were additionally associated with PAD outcomes, and their inclusion further improved risk discrimination (with C-statistic increases between 0.025 and 0.030). The inclusion of ambulatory 24-h SBP, instead of office SBP, also improved PAD risk discrimination. CONCLUSIONS: Increased CIMT and aortic stiffness are associated with greater risks of developing/progressing PAD, beyond traditional risk factors, in type 2 diabetes.
Authors: Vinodh Jeevanantham; Bassem Chehab; Edgar Austria; Rakesh Shrivastava; Mark Wiley; Peter Tadros; Buddhadeb Dawn; James L Vacek; Kamal Gupta Journal: Am J Cardiol Date: 2014-07-17 Impact factor: 2.778
Authors: Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini Journal: J Clin Endocrinol Metab Date: 2017-12-01 Impact factor: 5.958
Authors: J Dawn Abbott; Manuel S Lombardero; Gregory W Barsness; Ivan Pena-Sing; L Virginia Buitrón; Premranjan Singh; Gail Woodhead; Jean-Claude Tardif; Sheryl F Kelsey Journal: Am Heart J Date: 2012-10 Impact factor: 4.749
Authors: Kamel Mohammedi; Mark Woodward; Yoichiro Hirakawa; Sophia Zoungas; Bryan Williams; Liu Lisheng; Anthony Rodgers; Giuseppe Mancia; Bruce Neal; Stephen Harrap; Michel Marre; John Chalmers Journal: Diabetes Care Date: 2016-07-25 Impact factor: 19.112
Authors: Hester M Den Ruijter; Sanne A E Peters; Todd J Anderson; Annie R Britton; Jacqueline M Dekker; Marinus J Eijkemans; Gunnar Engström; Gregory W Evans; Jacqueline de Graaf; Diederick E Grobbee; Bo Hedblad; Albert Hofman; Suzanne Holewijn; Ai Ikeda; Maryam Kavousi; Kazuo Kitagawa; Akihiko Kitamura; Hendrik Koffijberg; Eva M Lonn; Matthias W Lorenz; Ellisiv B Mathiesen; Giel Nijpels; Shuhei Okazaki; Daniel H O'Leary; Joseph F Polak; Jackie F Price; Christine Robertson; Christopher M Rembold; Maria Rosvall; Tatjana Rundek; Jukka T Salonen; Matthias Sitzer; Coen D A Stehouwer; Jacqueline C Witteman; Karel G Moons; Michiel L Bots Journal: JAMA Date: 2012-08-22 Impact factor: 56.272
Authors: Jian L Yeo; Gaurav S Gulsin; Emer M Brady; Abhishek Dattani; Joanna M Bilak; Anna-Marie Marsh; Manjit Sian; Lavanya Athithan; Kelly S Parke; Joanne Wormleighton; Matthew P M Graham-Brown; Anvesha Singh; J Ranjit Arnold; Claire Lawson; Melanie J Davies; Hui Xue; Peter Kellman; Gerry P McCann Journal: Cardiovasc Diabetol Date: 2022-05-28 Impact factor: 8.949
Authors: Claudia R L Cardoso; Cristiane A Villela-Nogueira; Nathalie C Leite; Gil F Salles Journal: Cardiovasc Diabetol Date: 2021-09-24 Impact factor: 9.951